Regal Assets Analytics

Pharmaceuticals

Forget Mylan: The Government Should Immediately Investigate Mallinckrodt

By |2017-01-18T14:44:37-05:00September 6th, 2016|Categories: Chris Irons, Pharmaceutical & Biotechnology|Tags: , , , , , , |

By Christopher Irons for GeoInvesting Mallinckrodt's Acthar Gel may turn [...]

Ibio (AMEX:IBIO) – Claims Exclusive Rights in Certain Anti-Ebola Antibodies and Vaccines

By |2014-12-10T18:14:55-05:00October 13th, 2014|Categories: Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology|Tags: , , , , , , , , |

Ibio (AMEX:IBIO) Price Movement From Ebola/Enterovirus Hype Ibio (AMEX:IBIO) ($1.47) is a leading [...]

GeoTeam News 8/28/2014 >> XXII, DGLY, VII, ISNS, NHTC, VRYAF, CREG, LAS, ONP, SCLN, GOMO, SGOC, VNET, CCUR, IG

By |2014-10-21T20:58:25-04:00August 28th, 2014|Categories: Insights|Tags: , , , , , , , , , , , , |

Call(s) to Action: XXII, DGLY, NHTC, VRYAF The GeoTeam offers [...]

Comments Off on GeoTeam News 8/28/2014 >> XXII, DGLY, VII, ISNS, NHTC, VRYAF, CREG, LAS, ONP, SCLN, GOMO, SGOC, VNET, CCUR, IG